Question $4$

In the FDA's GLP regulations, one section initially appeared to place too great a responsibility on a single group. In response to public comments on the proposed rule, the FDA agreed to move some items from the

Quality assurance unit $($QAU$)$ to the study director

Study director to the quality assurance unit $($QAU$)$

Management to the study director

Study director to management